GYNECOLOGY: OFFICE GYNECOLOGYThermal Ablation Versus Cryotherapy or Loop Excision to Treat Women Positive for Cervical Precancer on Visual Inspection With Acetic Acid Test Pilot Phase of a Randomised Controlled TrialPinder, Leeya F.; Parham, Groesbeck P.; Basu, Partha; Muwonge, Richard; Lucas, Eric; Nyambe, Namakau; Sauvaget, Catherine; Mwanahamuntu, Mulindi H.; Sankaranarayanan, Rengaswamy; Prendiville, WalterAuthor Information Department of Obstetrics and Gynecology, University of Washington, Seattle, WA (L.F.P.); Department of Obstetrics and Gynecology, Women and Newborn Hospital (M.H.M.), and Obstetrics and Gynecology (L.F.P., G.P.P.), University of Zambia, Lusaka, Zambia; Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC (G.P.P.); Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer, World Health Organization, Lyon, France (P.B., R.M., E.L., C.S., W.P.); UNC Global Project–Zambia, Lusaka, Zambia (N.N.); and Research Triangle Institute, International–India, Commercial Tower, Pullman Hotel Aerocity, New Delhi, India (R.S.) Obstetrical & Gynecological Survey: May 2020 - Volume 75 - Issue 5 - p 291-292 doi: 10.1097/01.ogx.0000661548.12771.3d Buy Metrics Abstract (Abstracted from Lancet Oncol 2020;21:175–184) The most commonly used approach for women with cervical precancer in low-income and middle-income countries (LMICs) is screening by visual inspection with acetic acid (VIA) followed by immediate cryotherapy of VIA-positive women (see-and-treat). There are a number of logistical problems with cryotherapy that have prompted development and evaluation of a cordless, lightweight, and battery-operated thermal ablator that has a much faster treatment duration (20–40 seconds) and does not require a gas supply. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.